The University of Toledo

Vicki Ramsey-Williams, MD, PhD

Assistant Professor Associate Director, Student Clerkship                                                email: vicki.ramsey-williams@utoledo.edu
SPECIAL INTERESTS Adult Epilepsy Multiple Sclerosis Neurology Education EEG Video/EEG Monitoring Dementia

EDUCATION

Ph.D. in Pharmacology: Medical College of Ohio, Toledo, Ohio, 1992

M.D.:  Medical College of Ohio, Toledo, Ohio, 1995-1999

Internship:  Medical College of Ohio, Toledo, Ohio, 1999-2000

Neurology Residency:  Medical College of Ohio, Toledo, Ohio, 2000-2003 

Fellowship:   Clinical Neurophysiology, Department of Neurology, University of Michigan, Ann Arbor, Michigan, 2003-2004

PROFESSIONAL APPOINTMENTS

Post-doctoral Research Scientist:  The Upjohn Company, 1992-1995
Neurologist: Toledo Neurological Associates, Inc., 2004-2006
Assistant Professor: University of Toledo, Toledo, Ohio, Department of Neurology, 2006 -

CERTIFICATIONS

American Board of Psychiatry and Neurology, 2004

SOCIETY MEMBERSHIP

American Academy of Neurology

AWARDS AND HONORS

Medical College of Ohio Award (for outstanding medical students), 1998

Medical College of Ohio Award, 1997

Predoctoral Fellowship Award, Medical College of Ohio Graduate School, 1987-1992

REPRESENTATIVE PUBLICATIONS

Ramsey, V.A., Tietz, E.I., and Rosenberg, H.C.  Chronic flurazepam differentially regulates a behavioral effect of GABA agonists.  Pharmacol. Biochem. Behav., 38:  659-63, 1991.

Wu, Y., Rosenberg, H.C., Chiu, T.H., and Ramsey-Williams, V.A.  Regional changes in [3H]zolpidem binding to brain benzodiazepine receptors in flurazepam tolerant rat:  Comparison with changes in [3H]flunitrazepam binding.  J. Pharmacol. Exp. Ther., 268(2):  675-82, 1994.

Ramsey-Williams, V.A., Wu, Y., and Rosenberg, H.C.  Comparison of anticonvulsant tolerance, crosstolerance, and benzodiazepine receptor binding following chronic treatment with diazepam or midazolam.  Pharmacol. Biochem. Behav., 48:  765-72, 1994.

Ramsey-Williams, V.A., and Carter, D.B.  Chronic triazolam and its withdrawal alters GABAA receptor   subunit mRNA levels:  an in situ hybridization study.  Mol. Brain Res., 43:  132-40, 1996.

RESEARCH INTERESTS

New treatments for Multiple Sclerosis
New treatments for Epilepsy